Neil S Horowitz
Overview
Explore the profile of Neil S Horowitz including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
151
Citations
1996
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Braga A, Paiva G, Barcellos M, Elias K, Horowitz N, Berkowitz R
Hematol Oncol Clin North Am
. 2024 Sep;
38(6):1149-1159.
PMID: 39242292
Complete and partial molar pregnancies arise from abnormal fertilization with marked proliferation of syncytiotrophoblasts. Earlier diagnosis has reduced the frequency of severe medical complications at presentation; however, the risk of...
12.
Young A, Lin L, Abel M, Badhey M, Lechner A, Horowitz N, et al.
Gynecol Oncol
. 2024 Sep;
190:215-221.
PMID: 39236483
Objective: To report the New England Trophoblastic Disease Center (NETDC) experience with atypical placental site nodules (APSN). Methods: The NETDC registry was reviewed from 2005 to 2022 and clinical data...
13.
Horowitz N, Deng W, Peterson I, Mannel R, Thompson S, Lokich E, et al.
J Clin Oncol
. 2024 Apr;
42(16):1914-1921.
PMID: 38574312
Purpose: To assess efficacy and toxicity of cisplatin (C) and gemcitabine (G) with intensity-modulated radiation therapy (IMRT) in patients with locally advanced vulvar cancer not amenable to surgery. Methods: Patients...
14.
Braga A, Lopes R, Campos V, Freitas F, Maesta I, Sun S, et al.
Gynecol Oncol
. 2023 Jul;
176:130-138.
PMID: 37524011
Objective: To relate the distance traveled from the patient's residence to the gestational trophoblastic neoplasia (GTN) reference center (RC) and the occurrence of unfavorable clinical outcomes, as well as to...
15.
Braga A, Balthar E, Souza L, Samora M, Rech M, Madi J, et al.
Clinics (Sao Paulo)
. 2023 Jul;
78:100260.
PMID: 37523979
Objective: To evaluate the efficacy of immunotherapy for GTN treatment after methotrexate-resistance or in cases of multiresistant disease, through a systematic review, as well as to present the first 4...
16.
Braga A, Andrade T, Souza M, Campos V, Freitas F, Maesta I, et al.
Gynecol Oncol
. 2023 Jan;
170:179-185.
PMID: 36706644
Objective: To describe the natural history of hydatidiform mole (HM) after intracytoplasmic sperm injection (ICSI), emphasizing the clinical and oncological outcomes, as compared to patients who had HM after spontaneous...
17.
Jareemit N, Therasakvichya S, Freitas F, Paiva G, Ramirez L, Berkowitz R, et al.
Gynecol Oncol
. 2023 Jan;
170:114-122.
PMID: 36682089
Objective: To investigate the efficacy and toxicity of etoposide, methotrexate, actinomycin D alternating with cyclophosphamide, and vincristine (EMACO) for treatment of gestational trophoblastic neoplasia, and for factors independently associated with...
18.
Braga A, Canelas A, Torres B, Maesta I, Pedrotti L, Bessel M, et al.
PLoS One
. 2022 Dec;
17(12):e0277892.
PMID: 36454778
Objective: To relate preevacuation platelet count and leukogram findings, especially neutrophil/lymphocyte ratios (NLR) and platelet/lymphocyte ratios with the occurrence of gestational trophoblastic neoplasia (GTN) after complete hydatidiform mole (CHM) among...
19.
Braga A, Paiva G, Cattai C, Elias K, Horowitz N, Berkowitz R
Expert Opin Pharmacother
. 2022 Nov;
24(2):245-258.
PMID: 36399723
Introduction: Gestational trophoblastic neoplasia (GTN) is a rare tumor that arises from trophoblastic tissues with high remission rates after chemotherapy treatment. GTN can develop from any gestational events, such as...
20.
Campos V, Paiva G, Padron L, Freitas F, Pedrotti L, Sun S, et al.
BJOG
. 2022 Oct;
130(3):292-302.
PMID: 36209485
Objective: To assess whether the incidence and aggressiveness of molar pregnancy (MP) and postmolar gestational trophoblastic neoplasia (GTN) changed during the COVID-19 pandemic. Design: Observational study with two separate designs:...